Combination therapy in the era of immunotherapy

Anne-Marie Dingemans (Netherlands)

Source: New biomarkers, molecules and therapeutic sequences for non small cell lung carcinoma in the era of precision medicine

Number: 15

Disease area: Thoracic oncology

Rating:

You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Anne-Marie Dingemans (Netherlands). Combination therapy in the era of immunotherapy. New biomarkers, molecules and therapeutic sequences for non small cell lung carcinoma in the era of precision medicine

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.

You must Login to comment this presentation.

Related content which might interest you:

Optimisation of chemotherapy in the era of immunotherapy Source: Eur Respir J, 52 (4) 1801698; 10.1183/13993003.01698-2018 Year: 2018
First-line therapy Source: European Multidisciplinary Conference in Thoracic Oncology 2009 Year: 2009
Concomitant radiotherapy and targeted therapies Source: International Congress 2019 – New perspectives in thoracic surgical oncology Year: 2019
Surgery in the era of immune and targeted therapy Source: Virtual Congress 2021 – Diagnostic and therapeutic advances in mesothelioma care Year: 2021
Systemic therapies: optimising the sequences of chemotherapies, targeted therapies and immunotherapies Source: International Congress 2017 – PG1 Re-defining the role of chest physicians in lung cancer: new opportunities in diagnostics and therapy Year: 2017
Role of chemotherapy and radiation therapy Source: Annual Congress 2012 - PG10 An update on mesothelioma diagnostics and treatment Year: 2012
Current antiretroviral therapy Source: Eur Respir Monogr 2014; 66: 12-25 Year: 2014
Effectiveness of photodynamic therapy (PDT) in lung cancer treatment Source: Annual Congress 2009 - Treatment of lung cancer Year: 2009
Combination therapy may be beneficial for the treatment of lymphangioleiomyomatosis Source: Annual Congress 2013 –Cell signalling and inflammation: what's new in 2013? Year: 2013
Optimizing the target therapy development Source: ERS Research Seminar Year: 2015
Better diagnostics for targeted antibiotic therapy Source: Virtual Congress 2020 – Antibiotic resistance: the way forward Year: 2020
Combination immunotherapy in mesothelioma: managing expectations and new toxicities Source: Virtual Congress 2021 – Lung cancer grand round Year: 2021
Efficacy of traditional and combined therapy in patients with sarcoidosis Source: Eur Respir J 2003; 22: Suppl. 45, 234s Year: 2003
Pitfalls of neoadjuvant treatment Source: Annual Congress 2012 - Current challenges in multimodality lung cancer treatment Year: 2012